Treatment
Treatment
CAR T- Cell Therapy
Vaccine
Therapies
Procedures
Gene Therapy
Radiation Therapy
CAR T Cell Therapy for Leukemia
CAR T Cell Therapy for Lymphoma
CAR T Cell Therapy for Multiple Myeloma
CAR T Cell Therapy for Autoimmune Diseases
CAR T Cell Therapy for Liver Cancer
CAR T Cell Therapy in China
CAR T Cell Therapy in India
Conditions
Conditions
Hematology
Solid Tumors
Genetic Disorders
GI Cancer
Non-Hodgkin Lymphoma
Multiple Myeloma
MDS
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Aplastic Anemia
Hospitals & Doctors
Hospitals & Doctors
Doctors
Hospitals
Trials
Stories
Resources
About
🇬🇧
Connect With Us
🇬🇧
Home
/
Biomarkers
/
IDH2
IDH2
Mutated primarily in AML. Targeted by enasidenib.
Treatments
Drugs
Clinical Trials
No Clinical Trials found for this biomarker.
